Migraine Recent News
FDA Gives Nod To Nasal Spray Migraine Treatment From Impel NeuroPharma; Stock Jumps
Jim Cramer Says People Need To Know About Biohaven
Zosano Stock Surges After New Study Shows Qtrypta's Potential As Long-Term Treatment Option For Migraine
ElectroCore's Stock Is Trading Higher After Its Nerve Stimulator Wins Canadian Approval For Migraine
The Street May Be Underappreciating Alder Biopharma's Phase 3 Data
Piper Jaffray Defends Alder Despite Stock Slump, Looks To What's Next In Migraine Management
Alder Biopharmaceuticals' New Drug Promises Migraine Relief, Stock Rally